Brian Armstrong Argued Against Stalling AI Development

The Coinbase CEO claimed that slowing AI progress delays life-saving medical and safety technologies.

Updated on Sept. 23, 2026 in Artificial Intelligence

Bold flat-color editorial illustration depicting a fused silicon-wafer and neural-lattice structure, symbolizing the intersection of medical science and artificial intelligence.
Coinbase CEO Brian Armstrong argued this week that slowing artificial intelligence development hinders the delivery of life-saving medical and safety technologies. AI Illustration. Upload story photo >

Live Poll

Do you believe the rapid development of artificial intelligence is ultimately a safe and positive trend?

Coinbase CEO Brian Armstrong recently took to social media to push back against calls for slowing artificial intelligence development. He argued that impeding progress keeps potentially life-saving technologies from reaching the public.

Why it matters

The debate centers on whether to prioritize safety through controlled AI or to accelerate innovation to address global challenges. Proponents of rapid development believe that cautious regulation prevents humanity from solving issues that lead to daily mortality.

A national survey found that 25% of U.S. adults use artificial intelligence for health information, while 14 million have skipped a provider visit after receiving AI-generated advice. This occurs alongside a daily global death rate of 165,000 people.

The players

Brian Armstrong

He is the chief executive officer of the cryptocurrency exchange platform Coinbase.

Marc Andreessen

He is a prominent venture capitalist and co-founder of the venture capital firm Andreessen Horowitz.

David Sacks

He is a technology entrepreneur and venture capitalist known for his commentary on the industry.

Raoul Pal

He is a financial commentator and the founder of the financial media platform Global Macro Investor.

Anthony Pompliano

He is an entrepreneur and investor who frequently discusses the intersection of technology and finance.

The details

Brian Armstrong posted his stance on X, highlighting the potential for AI to mitigate causes of death such as cancer and heart disease. Meanwhile, industry figures like Marc Andreessen have pointed to OpenAI findings suggesting AI responses to medical questions can outperform those written by physicians.

Timeline

  1. July 2026: Marc Andreessen discussed OpenAI medical response findings.

  2. Early September 2026: David Sacks noted shifts in the political debate surrounding AI development.

  3. Mid-September 2026: Raoul Pal warned that AI could develop goals independent of human constraints.

  4. September 22, 2026: Brian Armstrong published his comments on X.

Deeper Dive

The argument mirrors findings from OpenAI medical response benchmarks that evaluate AI accuracy against human standards. This highlights the industry shift toward using specific diagnostic performance data to justify the necessity of rapid deployment.

Readers are increasingly relying on AI for personal health guidance, which directly influences their decisions to seek professional care. This shift could change how patients interact with the medical system and manage their own healthcare routines.

The takeaway

The ongoing debate highlights a tension between the pursuit of rapid innovation and the necessity of safety guardrails in emerging technologies. Individuals should weigh the convenience of AI-generated advice against the importance of professional medical consultation for critical health decisions.

Further reading

For more context on the current industry landscape, visit the Artificial Intelligence section.

Source note: This article includes information reported by Benzinga.

Live Poll

Do you believe the rapid development of artificial intelligence is ultimately a safe and positive trend?